BN — All updates

4 entries loaded; 0 direction changes

Filter loaded records
The Motley FoolPublished 2026-11-16
“Spelling Out Intrinsic Value Using the Alphabet”
$BNBullish
AI summary · Brookfield trades near $42 against management's roughly $67 per-share intrinsic-value estimate, a large discount the speaker finds attractive despite caution that the estimate relies on management's growth and rate assumptions; he credits CEO Bruce Flatt's two-decade record, cites roughly 15% annual compounding and AI-driven alternative-asset demand, while commercial real estate is beaten down by rates. He advises a bull/base/bear range and asking what it is worth if things do not go perfectly.

Matt, we're going to turn to you here with Brookfield. And this is very interesting for this conversation because it is one of the few companies out there that I'm aware of that actually gives its investors its own intrinsic value estimate.

Yeah. So, a few companies do that. And to be fair, when a company gives you an estimate of its own intrinsic value, remember who's making the estimate? It's the company. They're putting it in a presentation because they want to make their company look very valuable.

The Motley FoolPublished 2026-10-05
“Facing Our Investing Fears”
$BNBullish
AI summary · BN offers a favorable risk-reward profile due to business growth metrics outweighing recent price declines and acknowledged risks.

Another example, consider a company like Brookfield Corporation, whose stock market symbol is BN. The giant asset management company's shares have fallen by 20% over the past year, and have just reached their lowest level in 52 weeks.

Its distributable earnings, which are not earnings according to Generally Accepted Accounting Principles (GAAP) but rather a form of adjusted earnings, rose by 15% year-on-year in the last quarter.

Its fee-paying capital grew by 19 % year-on-year, a strong indicator of future revenues . It is raising funds at a faster pace than ever before. This is a situation where the business continues to grow, but the stock price is low due to market concerns.

There are some real risks with Brookfield , don't get me wrong. But the company, at a price of 15 times earnings, creates a remarkable risk-reward dynamic.

Daniel PronkPublished 2026-09-18
“Top 5 Lessons That Will Make You A Better Investor”
$BNBearish
AI summary · Reduced BN position due to underwhelming growth lowering DCF-based intrinsic value; thesis collapsed relative to alternatives.

This has already happened to me and my portfolio over the past year with respect to Brookfield. If you are a longtime follower of my channel, I'm sure you know that for almost 3 years I held Brookfield stock as the largest position in my portfolio by a considerable margin.

It performed very well in this position, and more than doubled my money during the period I owned the stock.

The Real Investment ShowPublished 2026-09-02
“9-2-26 Q&A Wednesday: What Are Markets Waiting For?”
$BNBearish
AI summary · BN is not suitable for a 5-8% portfolio weight due to an extended run beyond fundamentals, declining EPS/sales, high yield, and being overbought; max 2-3% weight only near $35.

I got a question about Brookfield uh Brookfield Corporation BN. Um question is is um what do you think of the company as a core compounder in the portfolio at a 5 to 8% weight? No.

And the reason is this. First of all, this company's had a huge run. This is a monthly chart by the way, not daily. Previous to this, over the previous, you know, kind of previous 2020, the stock was just growing at a very steady rate, very normal.

Yes, at that point you could have overweighted the stock. However, just in recent years, because of the speculation in the markets and a lot of the changes we've had and the way the markets are operating, you've had this massive extended run in Brookfield that is far beyond the fundamentals.

That's the earliest record
All updates for other tickers
Follow $BN30-day free trial
Start trial